Mini review · 30 Oct 2023
Case reportPublished 18 Feb 2021
Life threatening hepatotoxicity induced by Nilotinib.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Adverse events remain an obstacle to follow successful responding treatment. Solutions and manuscripts for monitoring drugs are essential, especially when it’s about a dangerous untoward occurrence. We report the case of 57 year-old woman with chronic myeloid leukemia who developed a rare life threatening hepatotoxicity (grade 4) secondary to Nilotinib? and how we ruled this. A monitoring of the disease as well as the treatment is mandatory.
Subjects
ToxicologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Experimental Toxicology.
Opinion · 30 Oct 2023
Decoding the invisible clues: The fascinating world of forensic toxicology.
Rapid communication · 30 Oct 2023
Beyond the surface: Unveiling the dangers of high hazard pesticides and pollutants.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Toxicology
- SubjectToxicology
- BylineArticles whose byline prints “Latifa Khelifa”
